Nyumbani › Leukemia › Ohio › Columbus
Majaribio ya kliniki ya Leukemia katika Columbus, OH
Masomo 12 ya Leukemia yanatafuta washiriki katika vituo vya Columbus na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
InaajiriHatua 3
- Quetzal Site 8, Columbus
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
InaajiriHatua 1/2
- Ohio State University, Columbus
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
InaajiriHatua 2
- Ohio State University Comprehensive Cancer Center, Columbus
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
InaajiriHatua 3
- Ohio State University, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
InaajiriHatua 1/2
- The Ohio State University Wexner Medical Center, Columbus
Hairy Cell Leukemia Patient Data Registry
InaajiriUtafiti wa uchunguzi
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
InaajiriHatua 1/2
- Dren Investigational Site, Columbus
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
InaajiriHatua 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
InaajiriHatua 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
InaajiriHatua 1
- The James Cancer Hospital and Solove Research Institute, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
InaajiriUtafiti wa uchunguzi
- Massive Bio SYNERGY-AI site, Columbus
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
InaajiriHatua 1
- The Ohio State University Wexner Medical Center - James Cancer Hosp, Columbus
Majaribio ya Leukemia katika miji mingine
- Houston, TXUtafiti 28
- Boston, MAUtafiti 25
- New York City, NYUtafiti 19
- Los Angeles, CAUtafiti 16
- Chicago, ILUtafiti 16
- Durham, NCUtafiti 13
- Baldwin Park, CAUtafiti 12
- Nashville, TNUtafiti 12
- Philadelphia, PAUtafiti 12
- Milwaukee, WIUtafiti 11
- Atlanta, GAUtafiti 11
- Seattle, WAUtafiti 11
Masomo mengine katika Columbus
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 56
- Saratani ya MatitiUtafiti 39
- Kansari ya MayaiUtafiti 39
- Saratani (aina zote)Utafiti 38
- Saratan ya MapafuUtafiti 37
- Leukemia ya Myeloid ya GhaflaUtafiti 35
- Leukemia ya Limfosaiti ya Muda MrefuUtafiti 28
- Saratani ya MetastasiUtafiti 27
- Saratani ya EndometrialUtafiti 25
- Kansari ya kolorektaliUtafiti 24
- Saratani ya ProstateUtafiti 24
- Multiple MyelomaUtafiti 24
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.